Agents Used in Antiretroviral Therapy

  • Authors: Philip Grant, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 9/10/19 (What's New)

Summary

    Ritonavir
    • Ritonavir is currently exclusively used as a pharmacologic booster at daily doses of 100-400 mg (Table 13)
    • Ritonavir is associated with gastrointestinal adverse effects and mild effects on cholesterol and triglycerides
    • Current 100-mg tablet formulation does not require refrigeration, unlike older capsule formulation
    Cobicistat

    Action required

    Keywords: Initial Antiretroviral Therapy, Special Populations, Treatment Complications

    ©2020 Clinical Care Options, LLC. All Rights Reserved.

    The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.